Buprenorphine - Prescribing Basics | Palliative Care Grand Rounds
503 بار بازدید -
2 ماه پیش
-
Recorded live on November 30th,
Recorded live on November 30th, 2023
Bupe...There it is! Part I
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr. Ho also discusses different formulations of buprenorphine in detail, including transdermal patches, buccal films, sublingual tablets, and injectable depot formulations. The appropriate dosing, titration, and administration of each formulation are explained, along with cost considerations. She also covers strategies for managing acute pain in patients already taking buprenorphine, such as splitting doses or adding a full opioid agonist like morphine or hydromorphone. Case studies are presented to illustrate the practical application of buprenorphine in various clinical scenarios. In her leture, Dr. Ho aims to equip healthcare professionals with the knowledge and skills to effectively incorporate buprenorphine into their practice for pain management and harm reduction in patients with opioid use disorder.
Claim CE credit at: https://stanford.cloud-cme.com/course...
Learning Objectives:
1. Provide an overview of buprenorphine's unique pharmacological properties
2. Discuss the various formulations of buprenorphine approved for pain management and opioid use disorder treatment
3. Provides guidance on appropriate dosing and administration of buprenorphine formulations
4. Discuss strategies for managing acute pain in patients already taking buprenorphine
5. Utilize the available resources, such as the buprenorphine task force, phone-a-friend support, and e-consult services, for guidance and advice on buprenorphine prescribing and management
Mitigation of Relevant Financial Relationships
Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education. For full disclosure information, please visit https://stanford.cloud-cme.com/course...
Bupe...There it is! Part I
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr. Ho also discusses different formulations of buprenorphine in detail, including transdermal patches, buccal films, sublingual tablets, and injectable depot formulations. The appropriate dosing, titration, and administration of each formulation are explained, along with cost considerations. She also covers strategies for managing acute pain in patients already taking buprenorphine, such as splitting doses or adding a full opioid agonist like morphine or hydromorphone. Case studies are presented to illustrate the practical application of buprenorphine in various clinical scenarios. In her leture, Dr. Ho aims to equip healthcare professionals with the knowledge and skills to effectively incorporate buprenorphine into their practice for pain management and harm reduction in patients with opioid use disorder.
Claim CE credit at: https://stanford.cloud-cme.com/course...
Learning Objectives:
1. Provide an overview of buprenorphine's unique pharmacological properties
2. Discuss the various formulations of buprenorphine approved for pain management and opioid use disorder treatment
3. Provides guidance on appropriate dosing and administration of buprenorphine formulations
4. Discuss strategies for managing acute pain in patients already taking buprenorphine
5. Utilize the available resources, such as the buprenorphine task force, phone-a-friend support, and e-consult services, for guidance and advice on buprenorphine prescribing and management
Mitigation of Relevant Financial Relationships
Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education. For full disclosure information, please visit https://stanford.cloud-cme.com/course...
2 ماه پیش
در تاریخ 1403/04/05 منتشر شده
است.
503
بـار بازدید شده